Cost of Albenza
Albenza is an anthelminthic drug. Its active substance is albendazole. The drug also has activity against pathogenic protozoa, effect on intestinal and tissue forms of parasites; actives against eggs, larvae and adult worms. Albenza is effective for most intestinal nematodosis and cestodoses (larval forms). Perhaps today we haven't another anti-parasitic drug with such a wide spectrum of action.
Albenza is an anthelminthic and antiprotozoal drug effective in the mono- and poly-invasion. It is especially effective against larval forms of cestodes - Echinococcus granulosus and Taenia solium, nematodes - Strongyloides stercolatis. The drug active substance is albendazole. Indications: neuro-cysticercosis, caused by the larval form of swine taenia; echinococcosis of the liver, lung, and peritoneum, caused by the larval form of the dog tape worm, and strongyloidiasis. Contraindications: hypersensitivity (including other benzimidazole derivatives), pathology of retina, pregnancy, lactation. Side effects: violations of the liver with the change in the functional liver tests (low or modest transaminase level increasing), oppression marrowy hematosis (lakopenia, granulocytopenia, agranulocytosis, thrombocytopenia, pancytopenia), increased body temperature, pain in the abdomen, nausea, vomiting, headache, dizziness, meningeal symptoms, high blood pressure, acute renal failure, alopecia, skin rashes, itching and other allergic reactions.
Cancer: Can testosterone improve patients' quality of life?
Many patients with cancer experience 'cachexia,' a condition characterized by loss of body mass and debilitating weakness. Can testosterone treat it?Tue, 17 Jul 2018, 10:00
What causes malabsorption?
Malabsorption occurs when the body is unable to absorb nutrients from the diet. There is a variety of malabsorption disorders that have different causes, including lactose intolerance. Symptoms might include bloating, diarrhea, and fatigue. Treatment is essential and depends on what is causing the malabsorption.Mon, 16 Jul 2018, 14:00